ALPS Advisors’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $179K | Sell |
23,140
-185
| -0.8% | -$1.35K | ﹤0.01% | 1030 |
|
|
2025
Q4 | $143K | Buy |
23,325
+10,224
| +78% | +$110K | ﹤0.01% | 1002 |
|
|
2025
Q3 | $241K | Sell |
13,101
-1,518
| -10% | -$24.4K | ﹤0.01% | 1003 |
|
|
2025
Q2 | $190K | Sell |
14,619
-5,330
| -27% | -$63K | ﹤0.01% | 1009 |
|
|
2025
Q1 | $211K | Sell |
19,949
-1,952
| -9% | -$31K | ﹤0.01% | 959 |
|
|
2024
Q4 | $372K | Buy |
21,901
+63
| +0.3% | +$1.19K | ﹤0.01% | 741 |
|
|
2024
Q3 | $507K | Sell |
21,838
-8,277
| -27% | -$177K | ﹤0.01% | 608 |
|
|
2024
Q2 | $733K | Buy |
30,115
+2,102
| +8% | +$63.7K | 0.01% | 520 |
|
|
2024
Q1 | $946K | Sell |
28,013
-207
| -0.7% | -$7.33K | 0.01% | 502 |
|
|
2023
Q4 | $890K | Sell |
28,220
-2,103
| -7% | -$50K | 0.01% | 510 |
|
|
2023
Q3 | $775K | Buy |
30,323
+10,799
| +55% | +$333K | 0.01% | 528 |
|
|
2023
Q2 | $560K | Buy |
+19,524
| New | +$531K | ﹤0.01% | 592 |
|
|
2022
Q4 | – | Sell |
-14,481
| Closed | -$215K | – | 1027 |
|
|
2022
Q3 | $215K | Sell |
14,481
-1,196
| -8% | -$20.1K | ﹤0.01% | 997 |
|
|
2022
Q2 | $247K | Sell |
15,677
-11,425
| -42% | -$224K | ﹤0.01% | 950 |
|
|
2022
Q1 | $731K | Sell |
27,102
-3,403
| -11% | -$86.8K | 0.01% | 343 |
|
|
2021
Q4 | $1.13M | Sell |
30,505
-1,754
| -5% | -$71.5K | 0.01% | 346 |
|
|
2021
Q3 | $1.54M | Sell |
32,259
-2,406
| -7% | -$108K | 0.01% | 346 |
|
|
2021
Q2 | $1.17M | Buy |
+34,665
| New | +$1.17M | 0.01% | 385 |
|
|
2020
Q4 | – | Sell |
-31,101
| Closed | -$1.33M | – | 839 |
|
|
2020
Q3 | $1.33M | Buy |
31,101
+3,148
| +11% | +$156K | 0.02% | 292 |
|
|
2020
Q2 | $1.31M | Buy |
+27,953
| New | +$963K | 0.02% | 275 |
|
Other funds holding ARCT
AIM
NAMA
VCM
VPM
